UBS Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.44M Buy
+421,100
New +$6.29M ﹤0.01% 4479

Other funds holding ALHC

UBS Group's ALHC Position: Q3 2026 in Review

UBS Group increased its Alignment Healthcare (ALHC) stake by 14% in Q3 2026, buying an estimated $2.97M and bringing the position to 1,618,789 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3112.

UBS Group first reported a position in ALHC in Q1 2021 and has held it in 23 quarters since. The position peaked at $33.8M in Q2 2026. 323 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • UBS Group held 1,618,789 shares of Alignment Healthcare worth $13.2M as of Q3 2026.
  • UBS Group bought 198,570 Alignment Healthcare shares in Q3 2026, an estimated $2.97M.
  • Alignment Healthcare made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #3112 holding.
  • UBS Group first reported a position in Alignment Healthcare in Q1 2021 and has held it in 23 quarters since.
  • UBS Group's Alignment Healthcare position peaked at $33.8M in Q2 2026.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.